This association between NfL levels and CAG repeat length suggests a dose–response relationship for SCA3 neurodegeneration and, together with analogous findings in Huntington's disease (Byrne et al, 2017), more generally for polyglutamine disorders. Here, ATXN3 is linked to Huntington disease.